siRNA therapeutics (Quark/Nitto Denko)

N/A

Report date: 2024/09/02 16:41:22

Base Information

Drug NamesiRNA therapeutics (Quark/Nitto Denko)
Drug Alias NameVA-Lip-siTIMP1-A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSbi Biotech Co LtdNitto Denko
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNitto DenkoSbi Biotech Co Ltd
Active IndicationsN/A
Inactive IndicationsLiver Cirrhosis

Other Information

ATC CodeN/A
Related LinksN/A